Skip to main content
PMC home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1994;72(1):89–99.

A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas.

P Garner 1, B Brabin 1
PMCID: PMC2486521  PMID: 8131256

Abstract

Current global recommendations for routine malaria chemoprophylaxis in pregnant women living in endemic malarious areas are not clear. To assist in policy formulation, the evidence from randomized controlled trials was reviewed. The literature was extensively searched, and studies identified were systematically analysed in relation to outcomes in the mother and the baby. Routine chemoprophylaxis appears to have an effect on antenatal morbid episodes and packed cell volume. There is a trend towards higher birth-weight values in chemoprophylaxis groups, which reached statistical significance in some studies. Evidence of an effect on gestation was only examined in one study. The effects on perinatal and neonatal mortality have only been examined in a few studies, with small sample sizes. The analysis questions whether routine malaria chemoprophylaxis is the best use of scarce resources in developing countries, and suggests that chemoprophylaxis might be targeted at anaemic women and primigravidae. Large controlled trials, with treatment available to placebo groups, are required to test whether routine chemoprophylaxis has advantages over early, effective treatment of clinical malaria.

Full text

PDF
89

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brabin B. J. An analysis of malaria in pregnancy in Africa. Bull World Health Organ. 1983;61(6):1005–1016. [PMC free article] [PubMed] [Google Scholar]
  2. Brabin B. J., Ginny M., Sapau J., Galme K., Paino J. Consequences of maternal anaemia on outcome of pregnancy in a malaria endemic area in Papua New Guinea. Ann Trop Med Parasitol. 1990 Feb;84(1):11–24. doi: 10.1080/00034983.1990.11812429. [DOI] [PubMed] [Google Scholar]
  3. Chalmers I., Hetherington J., Newdick M., Mutch L., Grant A., Enkin M., Enkin E., Dickersin K. The Oxford Database of Perinatal Trials: developing a register of published reports of controlled trials. Control Clin Trials. 1986 Dec;7(4):306–324. doi: 10.1016/0197-2456(86)90038-3. [DOI] [PubMed] [Google Scholar]
  4. Garner P., Kramer M. S., Chalmers I. Might efforts to increase birthweight in undernourished women do more harm than good? Lancet. 1992 Oct 24;340(8826):1021–1023. doi: 10.1016/0140-6736(92)93022-f. [DOI] [PubMed] [Google Scholar]
  5. Greenwood B. M., Greenwood A. M., Snow R. W., Byass P., Bennett S., Hatib-N'Jie A. B. The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy. Trans R Soc Trop Med Hyg. 1989 Sep-Oct;83(5):589–594. doi: 10.1016/0035-9203(89)90362-3. [DOI] [PubMed] [Google Scholar]
  6. Kaseje D. C., Sempebwa E. K., Spencer H. C. Malaria chemoprophylaxis to pregnant women provided by community health workers in Saradidi, Kenya. I. Reasons for non-acceptance. Ann Trop Med Parasitol. 1987 Apr;81 (Suppl 1):77–82. doi: 10.1080/00034983.1987.11812191. [DOI] [PubMed] [Google Scholar]
  7. Kramer M. S. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ. 1987;65(5):663–737. [PMC free article] [PubMed] [Google Scholar]
  8. MORLEY D., WOODLAND M., CUTHBERTSON W. F. CONTROLLED TRIAL OF PYRIMETHAMINE IN PREGNANT WOMEN IN AN AFRICAN VILLAGE. Br Med J. 1964 Mar 14;1(5384):667–668. doi: 10.1136/bmj.1.5384.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McGregor I. A., Wilson M. E., Billewicz W. Z. Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight. Trans R Soc Trop Med Hyg. 1983;77(2):232–244. doi: 10.1016/0035-9203(83)90081-0. [DOI] [PubMed] [Google Scholar]
  10. Mutabingwa T. K., Malle L. N., Mtui S. N. Chloroquine therapy still useful in the management of malaria during pregnancy in Muheza, Tanzania. Trop Geogr Med. 1991 Jan-Apr;43(1-2):131–135. [PubMed] [Google Scholar]
  11. Nahlen B. L., Akintunde A., Alakija T., Nguyen-Dinh P., Ogunbode O., Edungbola L. D., Adetoro O., Breman J. G. Lack of efficacy of pyrimethamine prophylaxis in pregnant Nigerian women. Lancet. 1989 Oct 7;2(8667):830–834. doi: 10.1016/s0140-6736(89)92998-x. [DOI] [PubMed] [Google Scholar]
  12. Nyirjesy P., Kavasya T., Axelrod P., Fischer P. R. Malaria during pregnancy: neonatal morbidity and mortality and the efficacy of chloroquine chemoprophylaxis. Clin Infect Dis. 1993 Jan;16(1):127–132. doi: 10.1093/clinids/16.1.127. [DOI] [PubMed] [Google Scholar]
  13. Victora C. G., Barros F. C., Vaughan J. P., Teixeira A. M. Birthweight and infant mortality: a longitudinal study of 5914 Brazilian children. Int J Epidemiol. 1987 Jun;16(2):239–245. doi: 10.1093/ije/16.2.239. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES